Clinical research

Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI

EuroIntervention 2014;9:1195-1201 published online ahead of print June 2013. DOI: 10.4244/EIJV9I10A201

Sorin J. Brener1,3*, MD; Jan-Henk Dambrink2, MD; Akiko Maehara3, MD; Saqib Chowdhary4, MD; Anthony H. Gershlick5, MD; Philippe Genereux3, MD; Jacques Koolen6, MD; Roxana Mehran7, MD; Martin Fahy3, MS; C. Michael Gibson8, MD; Gregg W. Stone9, MD

1. New York Methodist Hospital, Brooklyn, NY, USA; 2. Isala Klinieken, Zwolle, The Netherlands; 3. Cardiovascular Research Foundation, New York, NY, USA; 4. University Hospital of South Manchester, Manchester, United Kingdom; 5. NIHR Leicester Cardiovascu

Aims: To determine the relation between thrombus aspiration (TA) and/or intra-lesion (IL) abciximab with pre-stent Thrombolysis In Myocardial In

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

epicardial flowinfarct sizeintra-lesion abciximabstemi

Share on Facebook Share on Twitter Share on Linkedin